EKR Therapeutics chairman Rolf Classon resigns
Rolf A. Classon, chairman of the board and independent director of EKR Therapeutics, a privately held specialty pharmaceutical company, has resigned effective immediately and will not stand for re-election, according to a press statement from the company. The resignation comes just five months after Classon joined the specialty pharmaceutical company focused on providing acute-care specialty […]